TRANEXAMIC ACID
- Product NDC
- 71335-2695
- 11-digit product format
- 713352695
- Labeler code
- 71335
- Product ID
- 71335-2695_c616ecfa-42f7-49a2-898f-5aee4405c607
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TRANEXAMIC ACID
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA218320
- Marketing category
- ANDA
- Marketing start
- 2024-06-11
- Substance
- TRANEXAMIC ACID
- Active strength
- 650 mg/1
- Pharmacologic classes
- Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TRANEXAMIC ACID
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TRANEXAMIC ACID | 650 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6T84R30KC1 |
| Rxcui | 883826 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-2695-1 | TRANEXAMIC ACID | 8 in 1 BOTTLE | TABLET | 8 | | 1 |
| 71335-2695-2 | TRANEXAMIC ACID | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 71335-2695-3 | TRANEXAMIC ACID | 4 in 1 BOTTLE | TABLET | 4 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2695-1 | 71335269501 | 8 TABLET in 1 BOTTLE (71335-2695-1) | 8 tablet | 2025-09-24 | No | No | Historical |
| 71335-2695-2 | 71335269502 | 30 TABLET in 1 BOTTLE (71335-2695-2) | 30 tablet | 2025-09-24 | No | No | Historical |
| 71335-2695-3 | 71335269503 | 4 TABLET in 1 BOTTLE (71335-2695-3) | 4 tablet | 2025-09-24 | No | No | Historical |